Search for: "Insys"
Results 21 - 40
of 120
Sorted by Relevance
|
Sort by Date
16 Jan 2019, 5:59 am
Michael Babich, the former Insys CEO who resigned in 2015, admitted to conspiracy and mail fraud charges after entering into a cooperation deal with prosecutors. [read post]
18 May 2018, 7:15 am
Continue reading The post Federal Government Joins Whistleblower Suit Against Insys Therapeutics appeared first on Healthcare Fraud Lawyer Blog. [read post]
8 Nov 2019, 7:01 am
Doctor will spend time behind bars for involvement in Insys' Speakers Bureau scam. [read post]
16 Jun 2019, 9:18 am
Kapoor and other Insys execs await sentencing after their federal felony convictions. [read post]
2 Jun 2019, 6:11 am
Now, in a criminal case against the company, Insys and several executives “are accused of racketeering” to push sales. [read post]
10 Jun 2019, 11:00 am
Because of the extensive cooperation provided by Insys in the prosecution of culpable individuals and its agreement to enhanced CIA requirements, OIG elected not to pursue exclusion of Insys at this time. [read post]
28 Jan 2019, 10:33 am
The trial - of Insys founder John Kapoor and four other defendants - had been scheduled to start Monday morning. [read post]
25 Jul 2019, 7:44 am
The three former executives of Insys named as defendants in the new lawsuit are Michael Gurry, Insys’s former Vice President of Managed Markets; Michael Babich, Insys’s former Chief Executive Officer; and John Kapoor, Insys’s founder, as well as its former President, Chief Executive Officer, and Executive Chairman of the Board of Directors. [read post]
23 Jun 2022, 12:57 pm
In less than three years, Insys paid him over $278,000. [read post]
21 Jan 2021, 10:26 am
Kapoor, the founder of Insys Therapeutics (“Insys”), to resolve allegations that Kapoor orchestrated bribes to doctors in New Jersey as part of a nationwide kickback scheme to boost sales of Insys’ opioid drug known... [read post]
18 May 2018, 3:08 pm
The United States has separately pursued a number of criminal cases against Insys employees and Subsys prescribers.The cases allege illegal marketing tactics related to Subsys, a sublingual spray form of fentanyl, an opioid painkiller. [read post]
18 May 2018, 3:08 pm
The United States has separately pursued a number of criminal cases against Insys employees and Subsys prescribers.The cases allege illegal marketing tactics related to Subsys, a sublingual spray form of fentanyl, an opioid painkiller. [read post]
21 Aug 2019, 7:46 am
” “In a statement, a Weil representative said at no point was the firm representing adverse interests and said Simon was aware of its work for Insys ‘at the outset…In addition, Weil did not provide any advice to Insys or communicate with its other legal counsel with respect to whatever cooperation Insys provided to the Department of Justice in connection with the deferred prosecution agreement,’ the statement continued. [read post]
7 Jan 2015, 10:59 am
Insys aggressively marketed Subsys, its only brand-name product. [read post]
15 Oct 2019, 7:55 am
“Weil, Ex-Client Clash Over Possible Conflicts in Insys Work” — “A former sales executive at Insys Therapeutics who is seeking a new trial after a racketeering conviction has cited new evidence that he said shows his ex-lawyers at Weil, Gotshal & Manges kept him in the dark about potential conflicts posed by its simultaneous bankruptcy work for Insys. [read post]
7 Aug 2019, 12:21 pm
The former national sales director for Insys claims that Weil's concurrent representation of him and his employer posed a conflict that requires a new trial. [read post]
19 Nov 2019, 7:44 am
“Insys Exec Trial Fair Despite Alleged Weil Conflict, Judge Says” — “A convicted former Insys Therapeutics Inc. executive ‘got a fair trial’ despite Weil Gotshal & Manges LLP representing him during his criminal trial while guiding the company through its bankruptcy, a federal judge said following a fiery Thursday afternoon hearing over the alleged conflict. [read post]
15 May 2018, 12:54 pm
According to DOJ’s press release: On April 13, 2018, the United States intervened in five lawsuits accusing Insys Therapeutics Inc., of violating the False Claims Act in connection with the marketing of Subsys, an opioid painkiller manufactured and sold by Insys, the Department of Justice announced today. [read post]
10 Sep 2017, 6:49 pm
Claire McCaskill and investigators from a Senate committee, as well as federal prosecutors, have painted a harsh picture of how Insys created a special unit to boost sales and use of Subsys, its spray form of the potent painkiller fentanyl. [read post]
31 Jan 2020, 10:32 am
: Lessons from the Insys verdict. [read post]
